Abstract
Conclusion: Zinc supplementation is an effective, safe and feasible therapy for asthenospermic infertile males. It was associated with significant increase in sperm motility. (Rawal Med J 202;45:99-102). Results: Total 90 infertile males were included in study. Mean age of patients was 33.09±4.93 years. Baseline percent sperm motility was 2.05±3.33 and after 3 months percent sperm motility was 26.76±12.9SD (t=8.827, df=88, p=0.0000). Efficacy of zinc therapy is significantly associated with marriage duration (p<0.05) and insignificantly associated with age (p>0.05) Methodology: This descriptive study was conducted at Department of Urology, PAEC hospital, Islamabad from May 2015 to November 2015. WHO calculator was utilized for sample size calculation and Non probability sampling was used. Married males, age-18-50 years and lab findings showing asthenospermia were included in the study. Patients were provided with 20 mg zinc sulphate (per day) for time period of 3 months. Semen analysis was done for pre and post treatment sperm motility. Data were analyzed in SPSS. Comparison was done with independent t test and association was measured with ChiObjective:

Ghulam Mustafa, Hasham Khan, Muhammad Saqib Butt, Noor Un Nisa, Sarwat Saeed. (2020) Effectiveness of zinc administration in asthenospermia in infertile patients, , Volume 45, Issue-1.
  • Views 415
  • Downloads

Article Details

Volume
Issue
Type
Language
Received At
Accepted At